Prostate needle biopsy: 12 vs. 18 cores - Is it necessary?

Urologia Internationalis

Volumn 74, Issue 1, 2005, Pages 19-22

  Pepe, Pietro ^a   Aragona, Francesco ^a  

^a CANNIZZARO HOSPITAL   (Italy)

Author keywords

Extended prostate needle biopsy; Prostate cancer; Ultrasound guided prostate biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACINAR CELL; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CELL PROLIFERATION; CHRONIC PROSTATITIS; CONTROLLED STUDY; ECHOGRAPHY; GLEASON SCORE; HEMATURIA; HEMOSPERMIA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; URINE RETENTION; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; STATISTICS;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS;

EID: 18344387938     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082703     Document Type: Article

References (24)

1. Boccon-Gibod L: Rising PSA with a negative biopsy. Eur Urol 2001;40:3-8.
2. Scattoni V, Zlotta AR, Nava L, Roscigno M, Montorsi F, Rigatti P: Prostatic transrectal ultrasound (TRUS) guided biopsy schemes and TRUS prostatic lesion-guided biopsies. Eur Urol 2002;1:28-34.
3. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L: Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000;164:393-396.
4. Eskew LA, Bare RL, McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-202.
5. Hodge KK, McNeal JE, Terris MK, Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-75.
6. Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA: Sextant prostate biopsies: A histopathologic correlation with radical prostatectomy specimens. Cancer 1995;75:530-538.
7. Norberg M, Egevad L, Holberg L, Sparen P, Norlen BJ, Busch C: The sextant protocol for ultrasound-guided core biopsies of prostate underestimates the presence of cancer. Urology 1997;50:562-566.
8. Djavan B, Ravery V, Zlotta A: Pathological features and significance of prostate cancer detected on first, second, third and fourth repeat biopsy: when should we stop? (abstract). Eur Urol 2001;39:104.
9. Sedelaar M, Vijverberg P, De Rajke T: Transrectal ultrasound in the diagnosis of prostate cancer: State of the art and perspectives. Eur Urol 2001;40:275-284.
10. Pepe P, Panella P, Patanè D, Aragona F: Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer? Prostate Cancer Prostatic Dis 2003;6:159-162.
11. Brossner C, Winterholer A, Roehlich M, Dlouhy-Schutz E, Serra V, Sonnleithner M, Grubmuller KH, Pummer K, Schuster E: Distribution of prostate carcinoma foci within the peripheral zone: Analysis of 8,062 prostate biopsy cores. World J Urol 2003;21:163-166.
12. Beurton D, Izadifar V, Barthelemy Y, Desgrippes A, Fontaine E: 12 systematic prostate biopsies are superior to sextant biopsies for diagnosing carcinoma: A prospective randomised study. Eur Urol 2000;37(suppl 2):296-299.
13. de la Taille A, Antiphon P, Salomon L, Cherfan M, Porcher R, Hozem R, Saint F, Vordos D, Cicco A, Yiou R, Zafrani ES, Chopin D, Abbou CC: Prospective evaluation of 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003;61:1181-1186.
14. Fleshner N, Klotz L: Role of 'saturation biopsy' in the detection of prostate cancer among difficult diagnostic cases. Urology 2002;60:93-97.
15. Presti JC Jr: Prostate biopsy: How many cores are enough? Urol Oncol 2003;21:135-140.
16. Chan TY, Chan DY, Stutzman KL, Epstein JI: Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J Urol 2001;166:2181-2184.
17. Brossner C, Bayer G, Madersbacher S, Kuber W, Klinger C, Pychas R: Twelve prostate biopsies detect significant cancer volumes (>0.5 ml). BJU Int 2000;85:705-707.
18. Noguchi M, Stamey TA, McNeal JE, Yemoto CM: Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: Lack of prediction on significance for men with nonpalpable prostate cancer. J Urol 2001;166:104-109.
19. Borboruglu PG, Comer SW, Riffenburg RH, Amling CL: Extensive repeat transrectal ultrasound guided biopsy in patients with previous benign sextant biopsies. J Urol 2000;163:158-162.
20. Augustin H, Hammerer PG, Graefen M, Erbersdobler A, Blonski J, Daghofer F, Huland H: Insignificant prostate cancer in radical prostatectomy specimens time trends and preoperative prediction. Eur Urol 2003;43:455-460.
21. Gardner TA, Lemer ML, Schlegel PN, Waldbaum RS, Vaughan EE, Steckel J: Microfocal prostate cancer: Biopsy cancer volume does not predict actual tumour volume. Br J Urol 1998;81:839-843.
22. D'Amico AV, Wu MH, Nash M, Renshaw AA, Richie JP: Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of microscopic focus of prostate carcinoma with Gleason score
23. Bertaccini A, Scattoni V, Comerci F, Martorana G: The role of TRUS prostate biopsy quantitative histology in predicting the risk of extra-prostatic disease. Eur Urol 2002;1:76-82.
24. Epstein JI, Potter SR: The pathological interpretation and significance of prostate needle biopsy findings: Implications and current controversies. J Urol 2001;166:402-410.